# The Myocardial Protective Effects of a Moderate-potassium Blood Cardioplegia in Pediatric Cardiac Surgery

> **NCT01479049** · NA · COMPLETED · sponsor: **Xijing Hospital** · enrollment: 100 (actual)

## Conditions studied

- Congenital Heart Disease

## Interventions

- **DRUG:** MP (moderate potassium) group
- **DRUG:** HP (High potassium) group

## Key facts

- **NCT ID:** NCT01479049
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-03
- **Final completion:** 2010-10
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2011-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01479049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01479049, "The Myocardial Protective Effects of a Moderate-potassium Blood Cardioplegia in Pediatric Cardiac Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01479049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*